Laboratory Procedure – Page 2

Future-proofing gene therapy assays: Validation strategies for long-term success

4 months ago talkbio0Tagged Biological Assay, Develop, Long-term, Validation

Long-term, Validation, Biological Assay, Develop

Axplora Invests €50M in GLP-1 Manufacturing Expansion at Mourenx, France

5 months ago talkbio0Tagged alpha 1-antitrypsin, Axplora, biology (field), CDMO, Chromatography, Diabetes, expansion, France, Glucagon-Like Peptide 1, Manufacturing, Mourenx, Obesity, production

Axplora, GLP-1, manufacturing expansion, Mourenx, France, CDMO, API production, chromatography, diabetes, obesity, biologic therapies

LinusBio Introduces ClearStrand-ASD: Revolutionary Autism Diagnostic Aid Using Hair Analysis

6 months ago talkbio0Tagged Autistic Disorder, biomarker test, ClearStrand-ASD, Detection, Diagnosis, Exposome, Hair Analysis, LinusBio, Negative Predictive Value of Diagnostic Test

LinusBio, ClearStrand-ASD, autism diagnostic, hair analysis, biomarker test, early detection, negative predictive value, exposome medicine

23andMe Restructures, Cuts 40% of Workforce and Ends Therapeutics Division Amid Financial Struggles

8 months ago talkbio0Tagged financial struggles, Genetic testing for cancer risk, Transection (procedure)

23andMe, layoffs, therapeutics division, financial struggles, genetic testing, data security

TCT 2024: Johnson & Johnson’s Abiomed Successfully Completes Pivotal Study for Innovative Shrinkable Heart Pump, Impella ECP

9 months ago talkbio0Tagged Abiomed, Approved, High-Risk PCI, Impella, Johnson & Johnson, RNASE3 gene, Shock, Cardiogenic, Shrinkable Heart Pump, Thrombin Time Assay, United States Food and Drug Administration

TCT 2024, Johnson & Johnson, Abiomed, Impella ECP, Shrinkable Heart Pump, High-Risk PCI, Cardiogenic Shock, FDA Approval

GC Therapeutics Secures $75 Million Funding for Revolutionary Stem Cell Technology

10 months ago talkbio0Tagged Gas Chromatography, George Church, Stem cells, transcription factor screening

GC Therapeutics, George Church, stem cell startup, biotech funding, transcription factor screening

Coherus Biosciences Addresses Temporary UDENYCA Supply Interruption

10 months ago talkbio0Tagged Biosciences, Biosimilars, Cancer Therapeutic Procedure, Coherus, Disruption, Neulasta, pegfilgrastim, Pharmaceutical Supply Chain, Udenyca, White Blood Cell Count procedure

UDENYCA, Coherus Biosciences, supply interruption, biosimilar, pegfilgrastim, Neulasta, cancer treatment, white blood cell count, pharmaceutical supply chain.

Lilly’s Once-Weekly Insulin Efsitora Alfa Achieves Non-Inferiority in Four Phase 3 Trials

11 months ago talkbio0Tagged Administration occupational activities, Alfa, Diabetes, efsitora, Eli, Eli Lilly, Hemoglobin A1c measurement, Insulin, insulin therapy, non-inferiority, once-weekly, Phase 3 trials

Eli Lilly, efsitora alfa, once-weekly insulin, diabetes management, Phase 3 trials, non-inferiority, A1C reduction, insulin therapy.

Women Breaking Barriers in Drug Development: Celebrating Leadership and Innovation

11 months ago talkbio0Tagged Drug Development, Drug Industry, equity, Gender, innovation, Leadership, Scanning Transmission Electron Microscopy Procedures, Woman

Women in drug development, gender equity, STEM, pharmaceutical industry, leadership, innovation

Novo Nordisk Unveils Enhanced Cardiovascular Benefits of Semaglutide in Post-Hoc Analysis

11 months ago talkbio0Tagged Analysis of substances, Cardiovascular system, Diabetes, Nordisk, Obesity, outcomes, semaglutide

Semaglutide, Cardiovascular Outcomes, Obesity, Type 2 Diabetes, Novo Nordisk, Post-Hoc Analysis